Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05125796 |
Other study ID # |
2019-5-1 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
September 1, 2020 |
Est. completion date |
October 1, 2021 |
Study information
Verified date |
February 2024 |
Source |
Adiyaman University Research Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
In scorpion stings, patients mostly apply with the complaint of pain. Emergency physicians
need to relieve this pain quickly.
Description:
Aim: In this study, the analgesic efficacy of intravenous (IV) paracetamol, IV dexketoprofen
trometamol and topical lidocaine will be compared in patients presenting with pain after
scorpion sting.
Methods: This study is a double-blind, randomized, placebo-controlled study conducted in a
tertiary emergency department. Adult patients who applied to the study with no systemic
findings after scorpion sting and especially with pain will be randomly assigned to one of 4
groups: IV paracetamol, IV dexketoprofen trometamol, topical lidocaine or placebo. In order
to determine the intensity of pain, Visual Analog Pain Score (VAS) will be measured at the
time of admission to the emergency department, at the 30th minute and at the 60th minute.
Afterwards, the VAS score changes between the groups will be compared.